Search Results
Sangamo and Biogen's Gene Regulation Therapy to Fight Alzheimer's
Sangamo Therapeutics CEO on partnering with Biogen to develop gene-regulation therapies for Alzheime
Sangamo Therapeutics CEO: Alzheimer's and Parkinson's Gene Therapies | Mad Money | CNBC
Sangamo BioSciences
Sangamo Therapeutics
Genomic Medicines - Sangamo Therapeutics Inc.
Biogen Idec forges a $320M gene editing deal aimed at curing inherited blood disorders
Advancing Regenerative Therapies in Alzheimer’s and Cardiovascular Disease - Panel Discussion
087 - Sangamo Therapeutics Leverages Pharma Partnerships for Success!
"Advancing Treatment To Repair Our Aging Innate Immune System to Fight Alzheimer’s" INmune Bio(INMB)
The Role of New Technologies in Enabling Cell and Gene Therapies
Overcoming the blood-brain barrier for gene therapy delivery with AAV capsids. With Amy Pooler, PhD.
